Spazmalgon EFFECT (Drotaverine, Paracetamol) pills
2716USD

Spazmalgon EFFECT (Drotaverine, Paracetamol) pills

SKU:1647
To favorites
Spazmalgon EFFECT (Drotaverine, Paracetamol) a combined preparation, has an analgesic, anti-inflammatory, antispasmodic, antipyretic and analgesic effect
Active substance:Paracetamol, Caffeine, Naproxen, Drotaverine, Pheniramine
Pharmacological group:Pain relievers
Formulation:Tablets
Country of origin:Bulgaria
In stock
In stock
$7
We deliver goods to almost any country. Each parcel is assigned a track number
You can pay by Paypal or any card Visa or Mastercard
Discount system
Cumulative discounts and Bonus program for our clients
Original goods
We offer our customers only original products
Description
Характеристики
Отзывы

Instructions for Spazmalgon Effect (Drotaverine, Paracetamol) pills

Valid substance: (Paracetamol, Caffeine, Naproxen, Drotaverine, Pheniramine)

English product name
Spazmalgon Effekt

Release Form
Pills covered with film membranes

Description Spazmalgon:

Pills covered with green film envelope, double-bumped, elongated, on one side.

1 tab.
paracetamol 325 mg
perxen 100 mg
caffeine (waterless) 50 mg
drotaverine hydrochloride 40 mg
phenyramina Maleat 10 mg

Auxiliary substances: cellulose microcrystalline - 118.6 mg, starch corn pre-glagetinized - 30 mg, hyprolog - 20 mg, sodium croscarmelosis - 60 mg, or Monochrome acid - 10 mg, dynatry - 0.4 mg, ascorbic acid - 20 mg, thalk - 12 mg, magnesium stearat - 4 mg.

The composition of the film shell:
Opadra fx green 65 F210000 - 30 mg (polyvinyl alcohol - 14.1 mg,
thalk - 6.588 mg,
macro-goal - 3.99 mg,
pearlamuter pment - 3 mg,
polysorbat-80 - 0.81 mg, 
titanium dioxide - 0.75 mg,
aluminum lacquer based on indigocarmin dye - 0.507 mg,
aluminum lacquer based on Chinoli dy Yellow - 0.255 mg).

* Perlamuter pigment consists of saliva and contains 69-75% alumosilicate potassium (E555) and 25-31% titanium dioxide (E171).

10 - Blisters (1) - packs of cardboard.
10 - Blisters (2) - packs of cardboard.
10 - Blisters (3) - packs of cardboard.

ATX codes
N02BE71 Paracetamol in combination with psycholeptic

Pharmaceutical / Group Membership
Spazmalgon

Valid substance 
caffeine
paracetamol
drotaverine hydrochloride
perxen
phenyramina

Pharmaceutical group:

Analgesizing agent (MOTAPM+analgetizing drug+psycho-stimulant+spasmolitic+H1 histamine receptor)

Combination drug, provides analgesic, anti-inflammatory, spasmolithic, heat-reducing effect.

Paracetamol - a non-drug analgesik, has a heat-reducing and pain-relieving effect caused by the blockage of the TsOC in the CNS and the impact on the centers of pain and thermal regulation.

Naprxen - MOTAPM, provides anti-inflammatory, analgetizing and heat-reducing action related to non-selective suppression of the activity of the CTF regulating the synthesis of prostate glandins.

The caffeine causes the expansion of the blood vessels of skeletal muscles, hearts, kidneys; Improves mental and physical health, helps to eliminate tediousness and drowsiness; Increases the permeability of histogetic barriers and increases the bioavailability of non-arcotic analgesics, thereby increasing the therapeutic effect. Tone the brain vessels.

Drotaverin has a myotropic spasmolic effect caused by inhibiting phosphodiesterase IV, which affects the smooth muscles of LCDs, gastrointestinal paths, urinary system, vessels.

Feniramin is a blockage of H1-receptors histamine. It has a spasmolic and weak sedative effect, reduces the phenomenon of excision, and also strengthens the angeering effect of paracetamol and percussion.

Indications for use:

  • Diarrhoeal syndrome of various genes,
  • including joint, 
  • muscle, 
  • radiculite, 
  • algodismenorium, 
  • neuralgia, 
  • tooth pain, 
  • headache (including due to the spasm of the brain receptacles), 
  • Sickness syndrome associated with Smooth muscles, including chronic cholecystitis,
  • gastric disease,
  • post-cholecystomic syndrome, 
  • kidney colic, 
  • post-traumatic Post-operative pain syndrome, 
  • including inflammation, cold diseases accompanied by feverish syndrome (as symptomatic therapy).
Характеристики
Active substance
Pharmacological group
Formulation
Country of origin
Brand
Expiration Date (in months)
No reviews yet — your comment may be first.
All reviews 0
general rating